Funded Tech Companies

KaloBios Pharmaceuticals

KaloBios Pharmaceuticals, based in Brisbane, received equity investments through private investors, Genzyme Ventures and GBS Venture Partners.

Company Overview

Company Name
KaloBios Pharmaceuticals
Company Status
Publicly-held
Funding Rounds

Contact Information

Mailing Address
1000 Marina Blvd. 250
Brisbane, CA 94005
USA
Email Address

Company Background Information

Overview
KaloBios (NASDAQ: KBIO) is a vertically integrated therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics.
Profile
KaloBios Pharmaceuticals LinkedIn Company Profile
Social Media
KaloBios Pharmaceuticals Company Twitter Account
Company News
KaloBios Pharmaceuticals News
Facebook
KaloBios Pharmaceuticals on Facebook
YouTube
KaloBios Pharmaceuticals on YouTube
Last Transaction
1/31/2013

Financing History

Date
Type
Amount
IPO
$70,400,000
Venture Equity
$17,000,000
Venture Equity
$12,000,000
Venture Equity
$20,000,000
Venture Equity
$20,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Cameron Durrant
  Cameron Durrant LinkedIn Profile  Cameron Durrant Twitter Account  Cameron Durrant News  Cameron Durrant on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Kalm Therapeutics | Kalogon

 

Share this article

 


About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary